Cetirizine recall: Antihistamine tablets may be cross-contaminated and ‘life-threatening,’ says FDA

The U.S. Food and Drug Administration (FDA) is warning individuals to steer clear of select antihistamine tablets due to the fact that the tablets may be cross-contaminated with an ulcer-treating drug that can cause “serious adverse events”—including life-threatening ones—in people who are hypersensitive to the ingredients. Here’s what you need to know. What’s happened? This week, FDA published a recall notice for a voluntary recall that Unique Pharmaceutical Laboratories initiated over th...